Smith & Nephew SNATS (SNN) Getting Somewhat Favorable Press Coverage, Accern Reports

Back-tests of such patterns show that the break even failure rate is 10%, the average rise: 19%, the throwback rate: 61% and the percentage of stocks meeting their price targets: 40%. The California-based Oaktree Capital Management Lp has invested 3.09% in the stock. Northwestern Mutual Wealth Management Co. raised its position in shares of Smith & Nephew SNATS by 0.5% in the first quarter. Finally, HighTower Advisors LLC acquired a new stake in shares of Smith & Nephew SNATS during the first quarter valued at $242,000. If the $37.58 price target is reached, the company will be worth $1.07 billion more. (NYSE:SNN) was upgraded by investment analysts at BidaskClub from a "hold" rating to a "buy" rating in a research note issued on Tuesday, August 1st. The legal version of this news story can be read at https://www.com-unik.info/2017/08/11/j-p-morgan-chase-co-boosts-smith-nephew-plc-sn-price-target-to-gbx-1361-updated.html. Smith & Nephew plc has an average rating of Hold and a consensus target price of GBX 1,289.25 ($16.79). The stock had a trading volume of 338,100 shares. Northwestern Mutual Wealth Management Co. increased its stake in shares of Smith & Nephew SNATS by 0.5% in the first quarter.

Separately, Zacks Investment Research downgraded Smith & Nephew SNATS from a buy rating to a hold rating in a research report on Tuesday, June 27th. Smith & Nephew SNATS has a 12 month low of $26.97 and a 12 month high of $35.85. The stock's 50 day moving average is GBX 1,348.54 and its 200 day moving average is GBX 1,254.86. Four analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company.

Citigroup Inc. reaffirmed their sell rating on shares of Smith & Nephew plc (LON:SN) in a research note issued to investors on Monday, July 10th. Greenleaf Trust bought a new stake in shares of Smith & Nephew SNATS during the second quarter valued at approximately $207,000. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & global trademark & copyright law. Rock Point Advisors Llc owns 1.00 million shares or 3.41% of their U.S. portfolio. Wells Fargo & Company MN now owns 429,522 shares of the medical equipment provider's stock valued at $13,285,000 after buying an additional 75,572 shares during the last quarter. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.